A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users

Trial Profile

A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2010

At a glance

  • Drugs Ketamine; Lorcaserin; Zolpidem
  • Indications Drug abuse; Obesity
  • Focus Pharmacodynamics
  • Sponsors Arena Pharmaceuticals
  • Most Recent Events

    • 20 Mar 2010 Results have been presented at the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 10 Dec 2009 Positive data has been reported at the 48th Annual Meeting of the American College of Neuropsychopharmacology, according to an Arena Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top